Quantcast

Latest large cell lymphoma Stories

2014-03-10 23:24:25

Targeted drug aims to address high recurrence and lower survival in people with B-cell cancers. Raleigh, NC (PRWEB) March 10, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on new published research on an experimental Non-Hodgkin’s Lymphoma drug that appears to boost the power of existing medications. SNS01-T is a mixture of nanoparticles designed to interfere with the inner workings of malignant B-cells in patients with Non-Hodgkin’s Lymphoma and other B-cell cancers. A new...

2014-03-09 23:01:39

Two new studies in major medical journals may help doctors understand how Non-Hodgkin’s Lymphoma starts, and predict treatment outcomes. Raleigh, NC (PRWEB) March 09, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on new research suggesting that overweight Non-Hodgkin’s Lymphoma patients are just as likely to respond well to treatment as patients with lower BMIs. The report, published in the Annals of Oncology, is one of two new Non-Hodgkin’s Lymphoma risk studies....

2014-03-01 23:01:46

Korean researchers say a combination of techniques improves diagnostic accuracy for several types of Non-Hodgkin’s Lymphoma. Raleigh, NC (PRWEB) March 01, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on encouraging new research published in a medical journal called Diagnostic Cytopathology. Researchers from Yonsei University College of Medicine compared the diagnostic accuracy of two cell testing techniques and found that, when used together, they make it possible to not only...

2013-08-02 12:34:23

Weill Cornell scientists reveal how the protein works and how the drug gums it up, offering new hope for treatment of aggressive cancer Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma, itself the...

2013-07-29 10:49:47

Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy (ART) era in the US, according to a new study published July 26 in the Journal of the National Cancer Institute. Studies have shown that HIV infection increases the risk of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) and that incidence for many lymphoma types has not decreased in the ART era. Furthermore, lymphoma is the most frequent cancer-related cause of death among...

2013-06-26 10:16:52

Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it's the most common lymphoma subtype while in dogs, it's one of the most common cancers in veterinary oncology. A team of scientists from the University of North Carolina School of Medicine, North Carolina State University's College of Veterinary Medicine and Duke University have conducted one of the first studies to directly compare canine and human B-cell...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related